Research Status and Progress on Treatment of Advanced Gastric Cancer
10.3971/j.issn.1000-8578.2022.22.0596
- VernacularTitle:晚期胃癌治疗现状及进展
- Author:
Caixia DONG
1
;
Ying YUAN
Author Information
1. Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China
- Publication Type:Research Article
- Keywords:
Gastric cancer;
Chemotherapy;
Targeted therapy;
Immunotherapy
- From:
Cancer Research on Prevention and Treatment
2022;49(11):1095-1102
- CountryChina
- Language:Chinese
-
Abstract:
Gastric cancer is one of the most common malignant tumors worldwide. The number of gastric cancer cases and related deaths in China accounts for almost half of the global data. The survival prognosis of advanced gastric cancer is poor. With the development of individualized precision therapy, targeted therapy and immunotherapy have become the focus of comprehensive therapy. This paper reviews the latest research progress of chemotherapy, targeted therapy, and immunotherapy for advanced gastric cancer.
